Ripple Labs announced the purchase of GTreasury, a Chicago-based corporate treasury management company, for $1 billion on Thursday. This marks the company’s third major acquisition in 2025.
🔥UPDATE: from my prediction @Ripple just made a $1B power move 👀 By acquiring GTreasury, they're not just entering the corporate treasury space, they're bringing XRPL to Fortune 500 finance teams managing TRILLIONS in capital.
Legacy systems are about to meet real-time, 24/7… pic.twitter.com/kaU3i5tGGw
— PaulBarron (@paulbarron) October 16, 2025

The deal provides Ripple with tools to manage digital assets held in corporate treasuries. These assets include stablecoins and tokenized deposits that can generate yield for clients.
GTreasury’s treasury management software will work alongside Ripple’s blockchain infrastructure. This combination allows funds to be accessed around the clock with near-instant settlement for cross-border transactions.
Ripple CEO Brad Garlinghouse said the acquisition addresses problems with slow payment systems. He stated that money has been stuck in outdated infrastructure that causes delays and high costs.
Today, Ripple is breaking into the $120T corporate treasury payments market with the $1B acquisition of GTreasury.
The past few years have reminded this industry why payments, first and foremost, is THE primary use case for crypto and blockchain. Payments are where Ripple first…
— Brad Garlinghouse (@bgarlinghouse) October 16, 2025

The GTreasury purchase follows Ripple’s $1.25 billion acquisition of Hidden Road, a prime brokerage company, earlier in 2025. The company also acquired stablecoin platform Rail during the same period.
The two companies plan to focus on enabling customers to access the global repo market. They will also provide real-time cross-border payments at competitive rates.
Bloomberg reported that Ripple is leading an effort to raise at least $1 billion for a new XRP treasury. Sources familiar with the matter said the fundraise will occur through a special purpose acquisition company.
Ripple plans to contribute its own XRP holdings to the new entity. The details of the raise and transaction structure are still being discussed and may change.
If successful, this would become the largest digital asset treasury dedicated to XRP. In June, Singapore-based Trident Digital announced plans to raise $500 million for an XRP treasury.
The fundraising news comes as digital asset treasury companies face market challenges. Key firms including Strategy, Metaplanet, and BitMine have seen their market performance decline, with enterprise values falling below their crypto holdings.
Ripple has signed multiple partnerships with financial institutions in recent months. Spanish banking institution BBVA designated Ripple as its custodian for digital assets held for institutional clients in September.
Asset manager Franklin Templeton, DBS Bank, and Ripple signed a memorandum of understanding in September. The agreement launched tokenized trading services on the XRP Ledger using stablecoins and tokenized money market funds.
The partnership explores strategies for fund managers to move between stablecoins and other digital assets. This approach helps manage volatility while pursuing yield opportunities.
Ripple partnered with Bahrain Fintech Bay in October to offer digital asset custody services. The partnership integrates RLUSD dollar-pegged stablecoins into Bahrain’s digital asset ecosystem.
Bahrain Fintech Bay operates as a public-private partnership between Bahrain’s government and tech companies. It focuses on supporting financial technology startups.
These acquisitions and partnerships support Ripple’s effort to compete with the SWIFT interbank messaging system. SWIFT serves as the standard protocol for financial institutions to transfer money globally.
XRP, the fifth-largest cryptocurrency by market value, traded at $2.35 after falling 3.33% in the past 24 hours. The decline occurred during a broader cryptocurrency market downturn.
📈 Futures & Crypto Trader 🔍 Sharing charts, strategies, & mindset tips to help you level up 🚨 Not Financial Advice Follow on X @Pro_Trader_Edge
TLDR ZORA’s price surged 17% after listing on Upbit against KRW, BTC, and USDT. Bithumb…

Never Miss Another Opportunity.
Get hand selected news & info from our Crypto Experts so you can make educated, informed decisions that directly affect your crypto profits!
Type above and press Enter to search. Press Esc to cancel.
BC Game Crypto: 100% Bonus & 400 Free Casino Spins, Claim Here!

source

The Louisiana Lottery offers several draw games for those aiming to win big. Here’s a look at Oct. 16, 2025, results for each game:
3-4-6
Check Pick 3 payouts and previous drawings here.
4-3-1-5
Check Pick 4 payouts and previous drawings here.
7-3-7-9-9
Check Pick 5 payouts and previous drawings here.
Feeling lucky? Explore the latest lottery news & results
All Louisiana Lottery retailers will redeem prizes up to $600. For prizes over $600, winners can submit winning tickets through the mail or in person at Louisiana Lottery offices. Prizes of over $5,000 must be claimed at Lottery office.
By mail, follow these instructions:
Mail all of the above in a single envelope to:
Louisiana Lottery Headquarters
555 Laurel Street
Baton Rouge, LA 70801
To submit in person, visit Louisiana Lottery headquarters:
555 Laurel Street, Baton Rouge, LA 70801, (225) 297-2000.
Hours: 8 a.m. to 4:30 p.m., Monday through Friday. This office can cash prizes of any amount.
Check previous winning numbers and payouts at Louisiana Lottery.
This results page was generated automatically using information from TinBu and a template written and reviewed by a Louisiana editor. You can send feedback using this form.

source

Pi Network Price Prediction 2025: Pi Coin Price in 2025,2026, 2027 – 2030  CoinDCX
source

DC Lottery results: See winning numbers for DC 2, DC 3 on Oct. 16, 2025  Yahoo News Canada
source

Looking to win big? The Idaho Lottery offers several games if you think it’s your lucky day.
Lottery players in Idaho can chose from popular national games like the Powerball and Mega Millions, which are available in the vast majority of states. Other games include Lotto America, Lucky For Life, 5 Star Draw, Idaho Cash, Pick 3 and Pick 4.
Big lottery wins around the U.S. include a lucky lottery ticketholder in California who won a $1.27 billion Mega Millions jackpot in December 2024. See more big winners here. And if you do end up cashing a jackpot, here’s what experts say to do first.
Here’s a look at Thursday, Oct. 16, 2025 results for each game:
Day: 8-6-6
Night: 3-4-1
Check Pick 3 payouts and previous drawings here.
Day: 8-5-4-2
Night: 1-7-2-1
Check Pick 4 payouts and previous drawings here.
04-07-42-43-46, Lucky Ball: 11
Check Lucky For Life payouts and previous drawings here.
12-26-35-36-38
Check Idaho Cash payouts and previous drawings here.
Feeling lucky? Explore the latest lottery news & results
Winning lottery numbers are sponsored by Jackpocket, the official digital lottery courier of the USA TODAY Network.
Tickets can be purchased in person at gas stations, convenience stores and grocery stores. Some airport terminals may also sell lottery tickets.
You can also order tickets online through Jackpocket, the official digital lottery courier of the USA TODAY Network, in these U.S. states and territories: Arizona, Arkansas, Colorado, Idaho, Maine, Massachusetts, Minnesota, Montana, Nebraska, New Hampshire, New Jersey, New York, Ohio, Oregon, Puerto Rico, Washington D.C., and West Virginia. The Jackpocket app allows you to pick your lottery game and numbers, place your order, see your ticket and collect your winnings all using your phone or home computer.
Jackpocket is the official digital lottery courier of the USA TODAY Network. Gannett may earn revenue for audience referrals to Jackpocket services. GAMBLING PROBLEM? CALL 1-800-GAMBLER, Call 877-8-HOPENY/text HOPENY (467369) (NY). 18+ (19+ in NE, 21+ in AZ). Physically present where Jackpocket operates. Jackpocket is not affiliated with any State Lottery. Eligibility Restrictions apply. Void where prohibited. Terms: jackpocket.com/tos.
This results page was generated automatically using information from TinBu and a template written and reviewed by a USA Today editor. You can send feedback using this form.

source

Australia Cryptocurrency Exchange Market
Permanent link to this press release:

Delete press release

Edit press release

All 5 Releases

source

                                                           Let PharmaVoice's free newsletter keep you informed on what industry leaders are saying, straight from your inbox.                                                   <br><br>Partnerships have been key to building the company’s AI capabilities and patient-focused R&amp;D, said AstraZeneca’s head of U.S. oncology.<br>Among the strategies Big Pharma is employing to achieve more equitable health outcomes, AI is now playing a larger role. For AstraZeneca, a series of AI-based partnerships and screening initiatives is setting the stage to gather and use data for cancer patients in neglected ZIP codes.<br>As it stands, innovation is outpacing health equity, widening the gap in oncology between patients who have access to novel medicines and those who do not, said AstraZeneca’s senior vice president and head of U.S. oncology Mohit Manrao.<br>Black Americans have <a href="https://www.cancer.gov/about-cancer/understanding/disparities">higher death rates</a> than any other racial group for many cancer types, according to the NIH’s National Cancer Institute. Furthermore, people without access to healthcare are more likely to be diagnosed later in their disease trajectory, putting them at greater risk of death.<br>“Science is moving so fast, but the job isn’t done after that,” Manrao said. “The challenge we have at a local level is that disparities are increasing, and more and more people fall through the cracks. Everyone in the system has good intent, but it’s important that as an industry, we embrace opportunities and collaborate to solve for it.”<br>AI is one of the most promising opportunities for improved health equity, Manrao said. By teaming up with diagnostic makers and AI companies, AstraZeneca wants to use data to expose the disparities in care, and address screening and access issues that exacerbate them. Manrao said AstraZeneca’s mission goes beyond developing oncology meds like the blockbuster Enhertu, which was originally approved for breast cancer in 2019 and <a href="https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-enhertu-her2-positive-solid-tumors">recently scored a new expanded indication</a>, and AI can find patients who need it.<br>"The secret sauce for us, and it’s not truly secret, is external collaboration. What stands out for us and for anybody who wants to move the needle for patients is that we can’t work in silos."<br>Mohit Manrao<br>Head of U.S. oncology, AstraZeneca<br>“There is no reason that a Black woman with breast cancer in New York should have different outcomes than a white woman living in California or Atlanta — the ZIP code lottery exists today,” Manrao said.<br>Here, Manrao discusses the effect data-driven AI can have on the understanding and mitigating disparities in cancer care, the partnerships AstraZeneca has sought to bring AI into the fold, and how the feedback loop will also help drive better R&amp;D for more equitable outcomes down the road.<br><em>This interview has been edited for brevity and style.</em><br><strong>MOHIT MANRAO:</strong> Availability of data has multiplied in a multitude of ways, both in terms of genomic data and multi-omics data at a patient level and a customer engagement level.  Similarly, science, technology and data are converging very quickly, and that helps us believe we can have an impact on patients at every level. From a health equity lens, beyond our bread and butter in biopharmaceutical innovation, we want to start looking at the entire patient pathway and ask new questions. Are patients getting screened? What are the risk factors? Are they going to screening centers? Are they followed up appropriately in the system at the right intervals to be detected early?<br>Because of the socio-economic determinants of health, we need to have individualized interventions to solve for specific barriers that get in the way of a specific patient.<br>It’s a super important point. Being aware of bias that would get into a system and putting checks and balances around it can help us look at health equity. Across the pharmaceutical value chain, it starts with inclusive R&amp;D. We have drugs that get developed based on biosamples, and we’re working on creating diverse biosamples that are representative of the populations we serve. Of course, we can’t do that alone. So working at a local grassroots and community level to bring those diverse biosamples into drug development helps ensure that patient recruitment meets those goals. <br>For instance, at a clinical trial centered in a community in New Jersey that is 18% Black, we work with them to ensure that not only 18% is recruited from that community, but more so that we can help dig and gather data. And all this serves to help AI predict without bias.<br>When ChatGPT came out, it exploded into the world in a visible way, but we have been using AI in different parts of the value chain already. We have more than 700 data scientists who are AI experts working in different parts of our organization from early drug discovery to development to commercial organizations and operations. We’ve embedded them to think in terms of looking for partnerships — we can’t move forward alone. So looking at the right partners with the capabilities, values and vision in terms of transforming cancer care is very critical. For example, in early detection, there are a multitude of challenges. If we see that tissue-based screening is a challenge, we work with blood-based companies to look at how we can help improve their assay. That led us to <a href="https://grail.com/press-releases/grail-announces-strategic-collaboration-with-astrazeneca-to-develop-companion-diagnostic-tests-to-enable-the-treatment-of-early-stage-cancer/">work with Grail</a> in that space. <br><a href="http://qure.ai">Companies like Qure.ai</a> can use technology to find lung nodules on X-rays that a naked eye couldn’t see, and <a href="https://www.clinithink.com/news/clinithink-and-astrazeneca-launch-first-of-its-kind-ai-project-aimed-at-detecting-early-stage-lung-cancer#:~:text=Clinithink%2C%20the%20company%20that%20has,treatment%20can%20be%20more%20effective.">companies like Clinithink</a> have natural language processing that can go into electronic medical records. These are all important steps.<br>At the same time, let’s take the example of lung cancer — screening has been approved in the U.S. since 2013 and even a decade later, the uptake is dismal at only 5% to 6%. Socio-economic determinants are a barrier to lung cancer screening, and we’ve worked with the Association of Cancer Care Centers to understand and work with local communities, and use that rich data to inform where the pockets are, such as a <a href="https://www.accc-cancer.org/projects/appalachian-community-cancer-alliance/appalachian-community-cancer-alliance">rural Appalachian screening program</a> for lung cancer in Kentucky. <br>Similarly, we just announced a partnership with the University of Maryland system across counties in the state to identify at-risk populations. These academic and community institutes play a big part in the data-gathering process.<br>It’s critical that we put patients at the heart of drug discovery and development. All this data, in many ways, unlocks opportunities to uncover true unmet needs for patients, and the bigger picture is we want to eliminate cancer as a cause of death. Understanding through these datasets why the disease is progressing and informing R&amp;D by identifying patients earlier. The partnership with Grail, for instance, helps us not only identify patients but also to look at the data and [see] which patients within this group are high-risk and the kinds of interventions they need. So this is integrated across the internal value chain.<br>The secret sauce for us, and it’s not truly secret, is external collaboration. We don’t shy away from partnering with the right party. What stands out for us and for anybody who wants to move the needle for patients is that we can’t work in silos.<br>Get the free daily newsletter read by industry leaders<br>As another J&amp;J department bites the dust, leadership is focused on what&rsquo;s working in the pharma business, and there&rsquo;s plenty to see.<br>Keep up with the story. Subscribe to the PharmaVoice free daily newsletter<br>Subscribe to PharmaVoice for important stories, insights & perspectives<br>Get the free daily newsletter read by industry leaders<br>As another J&amp;J department bites the dust, leadership is focused on what&rsquo;s working in the pharma business, and there&rsquo;s plenty to see.<br>The free newsletter covering the top industry headlines<br><br><a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPU3JBcnV3VDhzbUtRSkNxcDN4eE1SZDZLZk5HMUVneFlRMmdpUFdVbFdUOTBfVGVfNGRyUUduZURYN0phTmZpMWwwR1dWOUxpZEZURGQyaF9FYVkya2s2TldvU3p5cHY3RHdrTDBqc19CN09ZdEo3Vll0SGdhZUcwNUJwVUdLZ2xNbEo1eGxFWlRoWW5RWXc?oc=5">source</a>

We participate in marketing programs, our editorial content is not influenced by any commissions. To find out more, please visit our Term and Conditions page.
We participate in marketing programs, our editorial content is not influenced by any commissions. To find out more, please visit our Term and Conditions page.
–
Ripple Labs is leading a $1 billion SPAC initiative. This entity will establish the world’s largest XRP digital asset treasury.
Ripple Labs is leading a massive fundraising initiative of at least $1 billion. The project aims to establish a powerful new digital asset treasury. This new large entity will be very interested in accumulating a large amount of XRP. The required capital will be raised by the SPAC mechanism. Further, Ripple will donate its XRP to the treasury. This move helps match corporate capital with growth in assets.
Bitcoin and Ether have been the big winners of the crypto market story this year. A strong stimulus to this particular orientation has been the dissemination of standards and practices in institutional adoption. However, XRP has had far less success in taking hold of the treasury of other digital assets (DATs) as a base asset. This major funding push aims at radically altering that market narrative. Ultimately, this campaign will help XRP to immediately enter the corporate mainstream.
Related Reading: Gumi Expands Digital Asset Treasury with Bitcoin and XRP | Live Bitcoin News
If this plan works out, the new entity would be the largest DAT devoted to XRP in the world. Trident Digital, the Singapore-based startup, with similar plans, was announced earlier. Trident has a goal of funding an XRP treasury with $500 million. Other large companies have followed suit with much smaller purses. However, none compares to the sheer scale that Ripple has imagined for the new treasury.
This ambitious venture could make XRP one of the first altcoins to find its way onto corporate treasuries’ white list. The effort comes at a time when there is market discussion on the stability of digital asset treasuries. Moreover, shares in crypto-heavy companies have recently moved into the red on sector volatility. To take one example, Michael Saylor’s Strategy shares have been weak recently. This background adds to the potential danger.
Japanese company Metaplanet has also seen its share price swing as of late. Yet, Ripple planned expansion is a manifestation of its firm belief in its asset. The company is not at all affected by the short-term ups and downs in the market. As a result of this, the company feels that its asset is long-term value. This firm conviction stems from high confidence in XRP’s future utility.
The funds will come from a Special Purpose Acquisition Company (SPAC). This way of raising capital makes the process very fast. Furthermore, Ripple is donating some of its already existing corporate XRP to the treasury. This type of dual funding means that substantial capital is available at the start. An optimal structure that struck an effective balance between liquidity and strategic control.
If the plan is successful, it will instantly make Ripple the largest institutional holder of XRP. This move could be a major change in the way digital assets are utilized globally. Specifically, it affects their role as strategic corporate reserves. Therefore, this project can cause a strong new precedent for the institutionalization of altcoins. The development will be followed closely by the global market.
XRP has typically been less on institutional radar than other large coins. However, it goes to show that there has been a strong push to regain narrative momentum after a $1 billion target. The project brings the asset in sync with the conventional high-finance models. Ultimately, Ripple hopes to build a highly regulated and robust institutional product. This practice represents long-term commitment and stability.
Indeed, this move is a powerful counter-narrative to recent market pessimism. It is an indication that large players have an appetite for non-Bitcoin digital assets. As a result, the success of this DAT would open up vast institutional capital flow. Finally, this funding initiative is aimed at establishing XRP’s position in the future of corporate finance on a global scale.
LiveBitcoinNews is a leading online platform dedicated to providing the latest news and insights about Bitcoin and the broader cryptocurrency market. It offers timely updates on market trends, regulatory developments, technological advancements, and expert analyses, catering to both seasoned investors and newcomers in the digital currency space. The site features a variety of content, including articles, guides, interviews, and opinion pieces, making it a comprehensive resource for anyone interested in staying informed about the rapidly evolving world of cryptocurrencies.
Contact us: support@livebitcoinnews.com
© Copyright – Livebitcoinnews.com

source

San Francisco-headquartered enterprise blockchain company Ripple is raising $1 billion via a special acquisition company (SPAC) in order to set up an XRP treasury, Bloomberg reports. 
As part of the effort, Ripple will contribute some of its own tokens. 
Will XRP price surge? 
Ripple is definitely on a roll right now, given that the Bloomberg report comes shortly after the company announced that it had agreed to acquire treasury management company GTreasury for $1 billion. 
The bullish news, however, has had virtually no impact on the XRP price, which is down by nearly 3% over the past 24 hours. 
As noted by analyst Bill Morgan, Ripple announcements rarely have an immediate or short-term impact on the price of the token, especially when it is not immediately obvious how they will affect XRP. 
Too late to the party? 
Ripple's entry into the digital asset treasury (DAT) space comes at a time when the euphoria surrounding this business model, pioneered by Strategy's Michael Saylor, has already peaked.
Even permabull Tom Lee, who rose to prominence after spearheading BitMine's transformation into an Ethereum treasury firm earlier this year, recently admitted that the bubble has seemingly burst. 
In a stunning reversal, many DAT firms, including such prominent names as Metaplanet, are now trading below their net asset value.
Other XRP treasury players 
Unlike Bitcoin and Ethereum, XRP has attracted relatively little attention from DAT firms. 
However, there are still several names that have adopted the token as a treasury asset. These include VivoPower International, Webus International, Wellgistics Health, Trident Digital Tech, and some other minor players. 
As reported by U.Today, Bitwise CEO Hunter Horsley previously predicted that Ripple could be viewed as an XRP treasury company. 
Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.Copyright © 2025, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by Quartr.© 2025 TradingView, Inc.

source

Q3 2025 Cryptocurrency Industry Report  富途牛牛
source